Watson P, Bützow R, Lynch H T, Mecklin J P, Järvinen H J, Vasen H F, Madlensky L, Fidalgo P, Bernstein I
Department of Preventive Medicine, Creighton University School of Medicine, Omaha, Nebraska 68178, USA.
Gynecol Oncol. 2001 Aug;82(2):223-8. doi: 10.1006/gyno.2001.6279.
Hereditary nonpolyposis colorectal cancer (HNPCC) is a hereditary cancer susceptibility disorder associated with a very high risk for carcinoma of the colon and an elevated risk for certain extracolonic cancers including ovarian cancer. Our aim in this study was to describe the clinicopathologic features of ovarian cancer in HNPCC family members.
. Members of the International Collaborative Group on HNPCC collected retrospective data on 80 ovarian cancer patients who were members of HNPCC families, including 31 known mutation carriers, 35 presumptive carriers (by colorectal/endometrial cancer status), and 14 at-risk family members.
Mean age at diagnosis of ovarian cancer was 42.7. Nonepithelial tumors made up only 6.4% of the cancers, and borderline tumors comprised just 4.1% of the epithelial cancers. Among frankly malignant epithelial cases, most cancers were well or moderately differentiated, and 85% were FIGO stage I or II at diagnosis. Synchronous endometrial cancer was reported in 21.5% of cases.
Ovarian cancer in HNPCC differs from ovarian cancer in the general population in several clinically important respects. It occurs at a markedly earlier age. It is more likely to be epithelial. If it is a frankly invasive epithelial cancer, it is more likely to be well or moderately differentiated. HNPCC patients with ovarian cancer are more likely to have a synchronous endometrial cancer than other ovarian cancer patients and are more likely to be diagnosed at an early stage.
遗传性非息肉病性结直肠癌(HNPCC)是一种遗传性癌症易感性疾病,与结肠癌的高风险以及包括卵巢癌在内的某些结肠外癌症的风险升高相关。本研究的目的是描述HNPCC家族成员中卵巢癌的临床病理特征。
HNPCC国际协作组的成员收集了80例HNPCC家族成员中卵巢癌患者的回顾性数据,其中包括31名已知的突变携带者、35名推定携带者(根据结直肠癌/子宫内膜癌状态)和14名高危家庭成员。
卵巢癌的平均诊断年龄为42.7岁。非上皮性肿瘤仅占癌症的6.4%,交界性肿瘤仅占上皮性癌症的4.1%。在明显恶性的上皮性病例中,大多数癌症为高分化或中分化,85%在诊断时为FIGO I期或II期。21.5%的病例报告有同步性子宫内膜癌。
HNPCC患者的卵巢癌在几个临床上重要的方面与一般人群中的卵巢癌不同。它发病年龄明显更早。更可能是上皮性的。如果是明显浸润性上皮癌,则更可能是高分化或中分化。与其他卵巢癌患者相比,HNPCC患者发生卵巢癌时更可能有同步性子宫内膜癌,且更可能在早期被诊断。